PD effluent specimen collection: Your questions answered.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
11 2023
Historique:
medline: 10 11 2023
pubmed: 8 12 2022
entrez: 7 12 2022
Statut: ppublish

Résumé

When a patient on peritoneal dialysis (PD) presents with suspected PD-related peritonitis (e.g. cloudy PD fluid and abdominal pain), one of the most important initial aspects of management is for the nephrology nurse/home dialysis nurse to collect PD effluent specimens for white blood cells count, Gram stain, culture and sensitivity for inspection and to send for laboratory testing before antibiotics are started. A review by seven members of the International Society for Peritoneal Dialysis (ISPD) Nursing Committee of all 133 questions posted to the ISPD website 'Questions about PD' over the last 4 years (January 2018-December 2021), revealed 97 posted by nephrology nurses from around the world. Of these 97 questions, 10 were noted to be related to best practices for PD effluent specimen collection. For our review, we focused on these 10 questions along with their responses by the members of the ISPD 'Ask The Experts Team', whereby existing best practice recommendations were considered, if available, relevant literature was cited and differences in international practice discussed. We revised the original responses for clarity and updated the references. We found that these 10 questions were quite varied but could be organised into four categories: how to collect PD effluent safely; how to proceed with PD effluent collection; how to collect PD effluent for assessment; and how to proceed with follow-up PD effluent collection after intraperitoneal antibiotics have been started. In general, we found that there was limited evidence in the PD literature to answer several of these 10 questions posted to the ISPD website 'Questions about PD' by nephrology nurses from around the world on this important clinical topic of best practices for PD effluent specimen collection. Some of these questions were also not addressed in the latest ISPD Peritonitis Guidelines. Moreover, when polling members of our ISPD Nursing Committee we found when answering a few of these questions, nursing practice varied within and among countries. We encourage PD nurses to conduct their own research on this important topic, focusing on areas where research evidence is lacking.

Identifiants

pubmed: 36475557
doi: 10.1177/08968608221136389
doi:

Substances chimiques

Anti-Bacterial Agents 0
Dialysis Solutions 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

442-447

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ana E Figueiredo (AE)

School of Health Sciences and Life, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegra, Brazil.

Elaine Bowes (E)

Kings College Hospital, NHS Foundation Trust, London, UK.

Josephine Sau Fan Chow (JSF)

Clinical Innovation & Business Unit, South Western Sydney Local Health District, Australia.
Faculty of Nursing, University of Sydney, Australia.
Faculty of Medicine, University of New South Wales, Sydney, Australia.
Faculty of Medicine, Western Sydney University, Australia.

Helen Hurst (H)

The University of Manchester, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, UK.

Joanna Lee Neumann (JL)

Satellite Healthcare, Inc., San Jose, CA, USA.

Rachael Walker (R)

Eastern Institute of Technology, Napier, New Zealand.

Gillian Brunier (G)

Sunnybrook Research Institute, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH